ロード中...
Stage IV EGFR Mutation-Negative and ALK Mutation-Negative Lung Adenocarcinoma: Long-Term Survival is Possible
Lung cancer is the leading cause of cancer death in the United States with a five-year survival of 16.8% for all stages and median survival of four months for Stage IV disease. We report a case of a 54-year-old male with a seven-year survival after being diagnosed with Stage IV epidermal growth fact...
保存先:
| 出版年: | Cureus |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cureus
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4725754/ https://ncbi.nlm.nih.gov/pubmed/26835190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.419 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|